Woven Orthopedic Technologies
Private Company
Total funding raised: $10M
Overview
Woven Orthopedic Technologies addresses a critical and common challenge in orthopedic surgery: achieving stable screw fixation in compromised bone. The company's flagship product, the Ogmend® Implant Enhancement System, is an off-the-shelf, implantable sleeve that enhances the stability between screws and bone, aiming to improve surgical outcomes, reduce procedure time, and lower costs. Founded by a surgeon who experienced the clinical need firsthand, Woven is a private, commercial-stage company targeting a significant global market for orthopedic fixation augmentation. Its value proposition centers on providing a simple, reliable solution for complex fixation scenarios where traditional hardware may fail.
Technology Platform
The Ogmend® Implant Enhancement System, an implantable sleeve that acts as a wall anchor to enhance screw fixation stability in compromised bone.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Woven competes indirectly with all major orthopedic implant companies (e.g., Stryker, Johnson & Johnson, Zimmer Biomet) whose core screw systems it aims to augment. Direct competition may come from other bone augmentation technologies (e.g., bone cements, expandable screws) and from potential future me-too products launched by large incumbents if the market proves attractive.